oncology
Novartis hires Merck president to lead oncology
June 3, 2014Medical Communications, Research and Development, Sales and Marketing Bruno Strigini, MSD, Merck, Novartis, oncology
Novartis has hired Merck’s president of Europe and Canada Bruno Strigini to be its president of oncology. The role was …
GSK signs Adaptimmune deal
June 3, 2014Manufacturing and Production, Research and Development, Sales and Marketing AZ, Adaptimmune, BMS, Cancer, GSK, oncology
GlaxoSmithKline has signed a deal to develop and commercialise biotech firm Adaptimmune’s lead clinical cancer programme with T-cell receptors (TCRs), …
BMS signs cancer deal
May 28, 2014Research and Development, Sales and Marketing ASCO, AstraZeneca, BMS, Cancer, Merck, Roche, cytomx, oncology
Bristol-Myers Squibb has partnered with CytomX Therapeutics to discover and develop new immuno-oncology candidates using the latter’s Probody Platform technology. …
Roche gets oncology boost with cancer vaccine
May 16, 2014Research and Development, Sales and Marketing ASCO, Roche, bladder cancer, oncology
Roche’s most advanced experimental cancer immunotherapy has had impressive results in a small Phase I trial, reducing tumour size in …
MedImmune signs Incyte oncology deal
May 15, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, Incyte, MedImmune, oncology
MedImmune, the global biologics R&D arm of AstraZeneca, is to put one of its oncology immunotherapies into development in combination …
Mekinist shown green light by CHMP
April 28, 2014Sales and Marketing CHMP, Cancer, GSK, mekinist, oncology, trametinib
GlaxoSmithKline’s melanoma drug Mekinist is virtually nailed on to be given approval in the European Union following a positive opinion …
Pfizer breast cancer drug combo aces trial
April 7, 2014Femera, Pfizer, breast cancer, oncology, palbociclib
Breaking into the oncology market
March 10, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, Cancer, NSCLC, edwards, gilotrif, oncology
In many ways, the US approval of Boehringer’s Gilotrif for patients with late-stage non-small cell lung cancer (NSCLC) last year …
Cobra agrees oncology deal with BioCancell
March 4, 2014Manufacturing and Production, Research and Development BC-821, Cobra, biocancell, oncology
Contract manufacturing organisation Cobra Biologics has signed a deal with specialist oncology biopharma firm BioCancell to manufacture an investigational cancer …
AbbVie expands into Singapore
February 10, 2014Manufacturing and Production, Sales and Marketing AbbVie, Abbott, Asia, Cancer, Singapore, oncology
AbbVie is expanding its manufacturing operation into Asia for the first time with a $320 million investment in a new …
AbbVie advances oncology drug
January 21, 2014Research and Development, Sales and Marketing AbbVie, DNA, oncology, veliparib
AbbVie has begun a Phase III trial of its investigational compound veliparib in women with early-stage, triple-negative breast cancer. This …
AstraZeneca strikes cancer vaccine pact
January 8, 2014Research and Development, Sales and Marketing AstraZeneca, Cancer, MedImmune, oncology
AstraZeneca’s biologics arm MedImmune has struck an oncology research deal with UK biotech company Immunocore. The deal, which could be …
Bayer in $2.9 billion Algeta deal
December 19, 2013Sales and Marketing Algeta, Bayer, oncology, xofigo
Bayer and Algeta have decided to avoid the usual M&A dance, opting instead to agree a business deal with little …
GSK launches cancer ‘consortium’
December 6, 2013Research and Development, Sales and Marketing Cancer, GSK, octc, oncology, research
GlaxoSmithKline has formed a consortium of cancer research organisations in North America and Europe in a bid to accelerate the …
Bayer targets Norway’s Algeta
November 27, 2013Sales and Marketing Algeta, Bayer, oncology, xofigo
Bayer HealthCare is in the market to buy Norwegian oncology specialist Algeta. The German pharma group has made a bid …
Latest content
FibroFind appoints Lee Borthwick as CEO
